Author:
Di Gregorio Emanuela,Miolo Gianmaria,Steffan Agostino,Corona Giuseppe
Funder
Ministero della Sanità 5x1000
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference18 articles.
1. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata;Pommier;Biochemistry,1996
2. A review of trabectedin (ET-743): a unique mechanism of action;D’Incalci;Mol. Cancer Ther.,2010
3. Role of macrophage targeting in the antitumor activity of trabectedin;Germano;Cancer Cell,2013
4. Yondelis | European Medicines Agency, (n.d.). https://www.ema.europa.eu/en/medicines/human/EPAR/yondelis (accessed November 25, 2019).
5. Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer;Colombo;Br. J. Cancer,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献